↓ Cooling
Business
🔮 holds
Eli Lilly's Market Cap Balloons, Again, On This IPO's Setback
Eli Lilly's market capitalization has risen following a setback for Kailera's oral GLP-1 obesity drug trials in China.
Hengrui Kailera's GLP-1
1 news trends Newsylist has tracked involving Hengrui Kailera's GLP-1 — newest first.